While synthetic nicotine products have been in a legal limbo for a while – including uncertainty as to whether PMTAs were actually necessary for them – now they have been put under the FDA’s regulatory authority. This is quite a different scenario from the one for tobacco-derived nicotine pouches, which have always been under the FDA’s regulatory authority, as they are derived from tobacco, and thus considered a “new tobacco product”.
This report asks and answers questions regarding US federal regulation on nicotine pouches, reviewing current law, looking at what stands to change, and clearing up what could happen if state and federal legislation clash.
Berta has a law degree from the University of Barcelona and a Juris Doctor degree from Nova Southeastern University (Florida). She has worked as a faculty assistant in legal research in Florida, was a member of the Law Review, and has interned for a magistrate judge of the US District Court for the Southern District of Florida.
Berta focuses on US legal analysis, including tracking all federal, state and local regulation. She runs our US interactive regulatory tracker product, following changing regulation on e-cigarettes in all 50 US states.
Our Key Benefits
The global novel nicotine market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.
TobaccoIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.
Stay informed of any legal and market change in the sector that impacts your organisation
Maximise resources by getting market and legal data analysis daily in one place
Make smart decisions by understanding how the regulatory and market landscape evolves
Anticipate risks in your decisions by monitoring regulatory changes that impact your organisation
Thanks for getting in touch with us
Please leave your enquiry and we will get back to you within 24 hours
"*" indicates required fields
Start your FREE trial
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis.
LATEST ALERTS
